fashion -WSS

fashion

author：comprehensive 2025-09-29 13:30:58 - browse：1322

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Pfizer highlights cancer drugs it thinks could reignite investor interest

leisure time

WSS

Why getting cancer drugs just got harder for rural patients

Flu vaccine offering decent levels of protection this winter, new data show

Christmas in the PICU brings some surprising joy

Flu vaccine offering decent levels of protection this winter, new data show

AstraZeneca loses challenge to Medicare drug price negotiation

How to keep neuroscience’s past racism from being its future

leisure time

fashion

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Clinical trials giant ICON acquires HumanFirst

Cancer drug shortages should be causing more outrage

In search for therapies for solid tumors, companies turn to claudin

23andMe had bad news about my health. I wish a person had delivered it

Christmas in the PICU brings some surprising joy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to fix the rural physician shortage in the U.S.

Bright Health sells Medicare Advantage business to Molina

Biotech companies concerned about China biosecurity crackdown

hotspot

What STAT readers think about the FDA and patient advocacy

An inside look at PIPEs, biotech's buzzy new financing tool

An inside look at PIPEs, biotech's buzzy new financing tool

Congress gives doctors Medicare pay bump

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

SEC charges former device maker CEO with $41 million fraud

Wikipedia

focus

leisure time

explore